Highlighted stocks traded at their 52 week high or low,
OR gained/lost more than 10% during the trading week.
Business Description :
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Dynamic Pharmaceutical Intellidex Index (the "index").
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index consists of common shares of companies that are principally engaged in research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.